The Europe corneal transplantation market is expected to grow from US$ 110.87 million in 2021 to US$ 160.88 million by 2028; it is estimated to grow at a CAGR of 5.5% from 2021 to 2028.
European countries are experiencing a significant increase in the geriatric patient population, especially those with an age greater than 80. As per the UN Population Aging 2019 report, the number of people aged 80 or above nearly tripled from 1990 to 2019 in the world. As the geriatric population increases, the demands for healthcare services required for this group also continue to grow. The aging of an ocular surface and corneal tissues, and the consequent impairment of visual functions lead to severe eye diseases and significantly impact vision. The conditions that affect these vital parts of the eye place a critical medical and socioeconomic burden on society. Corneal transplantation is a part of keratoplasty procedures, such as endothelial keratoplasty and penetrating keratoplasty. The geriatric population is highly susceptible to Fuchs' dystrophy, a condition treated by endothelial keratoplasty (EK). In addition, bullous keratopathy occurs in older adults undergoing cataract surgeries, such as EK. Thus, the increase in the population of elderlies is driving the overall growth of the Europe corneal transplant market.
With the new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the Europe corneal transplantation market. The Europe corneal transplantation market is expected to grow at a good CAGR during the forecast period.
Europe Corneal Transplantation Market Revenue and Forecast to 2028 (US$ Million)
Europe Corneal Transplantation Market Segmentation
The Europe corneal transplantation market is segmented based on type, indication, end user, and country. Based on type, the Europe corneal transplantation market is segmented into penetrating keratoplasty, descemet membrane endothelial keratoplasty (DMEK), descemet stripping endothelial keratoplasty (DSEK), corneal limbal stem cell transplant, and others. The penetrating keratoplasty segment dominated the Europe corneal transplantation market in 2020 and descemet membrane endothelial keratoplasty (DMEK) segment is expected to be fastest growing during forecast period. Based on indication, the Europe corneal transplantation market is segmented into fungal corneal ulcer, Fuchs dystrophy, keratoconus, keratitis, and others. The Fuchs dystrophy segment dominated the Europe corneal transplantation market in 2020 and same segment is expected to be fastest growing during forecast period. Based on end user, the Europe corneal transplantation market is segmented into hospitals, eye clinic, and ambulatory surgical centers. The hospitals segment dominated the Europe corneal transplantation market in 2020 and ambulatory surgical centers segment is expected to be fastest growing during forecast period. Based on country, the Europe corneal transplantation market has been segmented into the UK, Germany, France, Italy, Spain, and rest of Europe. Alcon Inc.; Aurolab; Cornea Biosciences, Inc.; Corneat Vision; Florida Lions Eye Bank; Keramed, Inc.; and Lifeline Scientific, Inc. are among the leading companies in the Europe corneal transplantation market.
Europe Corneal Transplantation Market Strategic Insights
Europe Corneal Transplantation Market Report Highlights
| Report Attribute | Details |
| Market size in 2021 | US$ 110.87 Million |
| Market Size by 2028 | US$ 160.88 Million |
| CAGR (2021 - 2028) | 5.5% |
| Historical Data | 2019-2020 |
| Forecast period | 2022-2028 |
| Segments Covered |
By Type
|
|
Regions and Countries Covered
|
|
| Europe | UK, Germany, France, Russia, Italy, Rest of Europe |
| Market leaders and key company profiles |
|
Europe Corneal Transplantation Market Country and Regional Insights
